Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENSE: 7 vs 14 Days Antibiotics for Enterococcal Bacteremia
NCT05394298Phase 4Unknown
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ampicillin, vancomycin, linezolid, daptomycin in enterococcal bacteremia (EB), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Status: unknown.
02
Drugs
ampicillinvancomycinlinezoliddaptomycin
03
Conditions
enterococcal bacteremia (EB)
Beyond the preview
Go deeper on NCT05394298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05394298.